Marstacimab

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Hemophilia aSevere Hemophilia aHemophilia

93 competitors in Hemophilia a

#DrugCompanyPhaseTrials

1

Hemlibra

Roche

Phase 3

162

Recombinant Human Coagulation FVIII

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 3

23

Eptacog Alfa

Novo Nordisk

Phase 3

14

Qfitlia

GGenzyme, a Sanofi Company

Phase 3

15

Valoctocogene Roxaparvovec

BioMarin Pharmaceutical

Phase 3

36

Recombinant Factor VIII

Bayer

Phase 3

27

Rfviia

Roche

Phase 3

18

PF-06741086

Pfizer

Phase 3

19

Refacto

Pfizer

Phase 3

410

Biostate

CSL Behring

Phase 3

2Show 26 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Hemophilia2 trials

A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.

Active, not recruiting·Pfizer··NCT07161687·50 enrolled

Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry

Not yet recruiting·IInstitute of Hematology & Blood Diseases Hospital, China··NCT06992076·100 enrolled

MPA1 trial

A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

Terminated·Pfizer·Phase 1·NCT04832139·22 enrolled

Severe Hemophilia a1 trial

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

Recruiting·Pfizer·Phase 1·NCT06703606·15 enrolled

Hemophilia A1 trial

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Recruiting·Pfizer·Phase 3·NCT05611801·100 enrolled

Details

Drug Info

Related News